Aratana Theraptcs
(PETX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2013 | 12-2012 | 12-2011 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 41,084 | 13,973 | 6,002 |
| Marketable Securities | 4,670 | 6,382 | 6,382 |
| Receivables | 1,001 | 650 | N/A |
| Inventories | 55 | N/A | N/A |
| Income taxes - deferred | 1,124 | N/A | N/A |
| TOTAL | $48,208 | $21,030 | $12,409 |
| Non-Current Assets | |||
| PPE Net | 98 | 19 | 23 |
| Intangibles | 64,000 | 0 | 0 |
| Other Non-Current Assets | 37 | 173 | 141 |
| TOTAL | $64,135 | $192 | $164 |
| Total Assets | $112,343 | $21,222 | $12,573 |
| Liabilities | |||
| Current Liabilities | |||
| Short Term Debt | 5,625 | N/A | N/A |
| Accounts payable and accrued liabilities | 2,307 | 761 | 225 |
| Accrued Expenses | 2,495 | 1,361 | 396 |
| Other current liabilities | 2,629 | 562 | 68 |
| TOTAL | $16,901 | $3,484 | $689 |
| Non-Current Liabilities | |||
| Long Term Debt | 9,310 | N/A | N/A |
| Deferred Revenues | 845 | 800 | N/A |
| Other Non-Current Liabilities | 1,618 | 96 | 0 |
| TOTAL | $12,052 | $96 | $N/A |
| Total Liabilities | $28,953 | $3,580 | $689 |
| Shareholders' Equity | |||
| Shares Outstanding, K | 29,477 | N/A | N/A |
| Common Shares | 23 | 1 | N/A |
| Retained earnings | -29,148 | -22,210 | -10,574 |
| Other shareholders' equity | 0 | 39,197 | 22,155 |
| TOTAL | $83,390 | $17,642 | $11,884 |
| Total Liabilities And Equity | $112,343 | $21,222 | $12,573 |